Identificador persistente para citar o vincular este elemento: https://accedacris.ulpgc.es/handle/10553/107275
Campo DC Valoridioma
dc.contributor.authorMartin, Rabellinoen_US
dc.contributor.authorVanesa G, Di Caroen_US
dc.contributor.authorRaleigh, Juan Valleen_US
dc.contributor.authorJose, Chasen_US
dc.contributor.authorVadim, Kotowiczen_US
dc.contributor.authorMaynar Moliner, Manuelen_US
dc.contributor.authorZander, Tobiasen_US
dc.date.accessioned2021-05-24T14:32:24Z-
dc.date.available2021-05-24T14:32:24Z-
dc.date.issued2021en_US
dc.identifier.issn1538-5744en_US
dc.identifier.otherScopus-
dc.identifier.urihttps://accedacris.ulpgc.es/handle/10553/107275-
dc.description.abstractBackground: Despite considerable morbid-mortality rates, common femoral endarterectomy is still considered the gold standard for atherosclerotic common femoral artery (CFA) disease. The aim of this study was to demonstrate computed tomography angiography based long-term patency after CFA stent placement and to analyze associated risk factors for restenosis. Methods: A retrospective and observational study was carried out in consecutive patients treated with endovascular stent placement in CFA lesions. A clinical follow-up and imaging study was performed using MD-CTA to assess different degrees of in stent restenosis (ISR) and primary, assisted, and secondary patency rates. Results: In a 5-year period, 35 extremities were treated in 33 patients with self-expandable nitinol stents. The technical success was 100% without complications related to the procedure. The mean follow-up (FU) was 32.2 months, and 8 limbs were lost. The degree of CFA stenosis was reduced from 79.69 ± 26.47% to 11.23 ± 24.53%. ISR < 20%, 20–70%, and ≥ 70% was evident in 15 (55.6%), 9 (33.3%), and 3 (11.1%) limbs, respectively. Estimated primary, assisted, and secondary patency was 79.5, 96.3, and 96.3%, respectively, after 24 months and 79.5, 96.3, and 96.3%, respectively after 60 months, with a freedom of clinical driven target lesion revascularisation rate of 87.8%. Conclusion: Endovascular treatment with self-expandable nitinol stents in CFA lesions had a high technical success rate and was related to few complications. A mild form of intimal hyperplasia was observed in a considerable number of cases. However, long-term patency was high; therefore, CFA stent placement might be a suitable therapeutic alternative in selected patients.en_US
dc.languageengen_US
dc.relation.ispartofVascular and Endovascular Surgeryen_US
dc.sourceVascular and Endovascular Surgery [ISSN 1538-5744], v. 55(6), p. 571-576en_US
dc.subject32 Ciencias médicasen_US
dc.subject321317 Cirugía vascularen_US
dc.subject.otherClaudicationen_US
dc.subject.otherCritical Limb Ischemiaen_US
dc.subject.otherPeripheral Artery Diseaseen_US
dc.subject.otherStenten_US
dc.titleCommon Femoral Artery Stenting: Computed Tomography Angiography Based Long-Term Patencyen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typearticleen_US
dc.identifier.doi10.1177/15385744211010447en_US
dc.identifier.scopus85105487574-
dc.contributor.authorscopusid57223281635-
dc.contributor.authorscopusid57223285151-
dc.contributor.authorscopusid57223300590-
dc.contributor.authorscopusid57223294615-
dc.contributor.authorscopusid57223301406-
dc.contributor.authorscopusid7005962555-
dc.contributor.authorscopusid24537953400-
dc.identifier.eissn1938-9116-
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.description.numberofpages6en_US
dc.utils.revisionen_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr0,43
dc.description.jcr1,046
dc.description.sjrqQ2
dc.description.jcrqQ4
dc.description.scieSCIE
dc.description.miaricds11,0
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Tecnología Médica y Audiovisual-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0001-9154-0712-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameMaynar Moliner,Manuel-
Colección:Artículos
Vista resumida

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.